Concepedia

Alice Abraham

AA

Statistics

Publications

5

Citations

226

H-Index

5

Active since

2013

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Mirati Therapeutics (United States)

Alice Abraham is an author at The University of Texas MD Anderson Cancer Center specializing in cancer therapeutics, urology, and radiation oncology.

Top concepts

Publications per year

2013–2023

5

Publications

5

Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer

Colin P. Dinney, Mark B. Fisher, Neema Navai et al. · The Journal of Urology · 2013 · 120 citations · Full text

Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma

José A. Karam, Pavlos Msaouel, Cara Haymaker et al. · Nature Communications · 2023 · 46 citations · Full text

Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette–Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer

Neema Navai, William F. Benedict, Guangcheng Zhang et al. · Annals of Surgical Oncology · 2016 · 35 citations · Full text

, , +7

Three-Month Randomized Clinical Trial of Nasal Calcitonin in Adults with X-linked Hypophosphatemia

Rebecca Sullivan, Alice Abraham, Christine Simpson et al. · Calcified Tissue International · 2018 · 14 citations · Full text

, ,

A phase II study of sitravatinib (Sitra) in combination with nivolumab (Nivo) in patients (Pts) undergoing nephrectomy for locally-advanced clear cell renal cell carcinoma (accRCC).

José A. Karam, Pavlos Msaouel, Surena F. Matin et al. · Journal of Clinical Oncology · 2021 · 11 citations

, , +22

1–5 of 5